Health economic burden of patients with phenylketonuria (PKU) – A retrospective study of German health insurance claims data
Friedrich K. Trefz(University Medical Center Groningen), Frank Rutsch(Klinik und Poliklinik für Kinder- und Jugendmedizin), J. Altevers, Ania C. Muntau(University Medical Center Hamburg-Eppendorf), Claudia Zeiss, Ashok Kumar Jha(BioMarin (United Kingdom)), Sebastian Braun(Goethe University Frankfurt), Paul Lane(BioMarin (United Kingdom)), Christian Jacob, Mohit Jain(BioMarin (United Kingdom)), Ignacio Alvarez(BioMarin (United Kingdom)), Kim Maren Schneider, Wolfgang Greiner(Bielefeld University)
Cited by 21
Related Papers
Barriers and Strategies in Guideline Implementation—A Scoping Review
|Healthcare|2016|946
Development of the EQ-5D-Y: a child-friendly version of the EQ-5D
|Quality of Life Research|2010|903
German Value Set for the EQ-5D-5L
|PharmacoEconomics|2018|618
Feasibility, reliability, and validity of the EQ-5D-Y: results from a multinational study
|Quality of Life Research|2010|476
A single European currency for EQ-5D health states
|The European Journal of Health Economics|2003|465